9 February 2021 Akston Biosciences Completes Second Licensing and Supply Agreement with Dechra Pharmaceuticals PLC
2 August 2019 Akston Biosciences Completes Licensing and Supply Agreement with Dechra Pharmaceuticals PLC
8 March 2023 Akston Biosciences Ends Vaccine Partnership with Stelis, Continues to Advance COVID Universal Booster EUA
1 November 2022 Akston Biosciences Announces Positive Interim Phase II Results from COVID “Universal” Booster Vaccine Trial